Chan AS et al. |
Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. |
2003 |
Oncogene |
pmid:14534543
|
Lu F et al. |
Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. |
2003 |
J. Virol. |
pmid:14557628
|
Siddiqui H et al. |
Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition. |
2003 |
Mol. Cell. Biol. |
pmid:14560017
|
Martin D et al. |
Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines. |
2003 |
J. Biol. Chem. |
pmid:14565956
|
Zhang Q et al. |
Inhibition and reversal of nickel-induced transformation by the histone deacetylase inhibitor trichostatin A. |
2003 |
Toxicol. Appl. Pharmacol. |
pmid:14575637
|
Usenko T et al. |
Transient expression of E1A and Ras oncogenes causes downregulation of c-fos gene transcription in nontransformed REF52 cells. |
2003 |
Oncogene |
pmid:14576829
|
Allison SJ and Milner J |
Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy. |
2003 |
Cancer Res. |
pmid:14583461
|
Chaturvedi V et al. |
Resistance to UV-induced apoptosis in human keratinocytes during accelerated senescence is associated with functional inactivation of p53. |
2004 |
J. Cell. Physiol. |
pmid:14584049
|
Mai A et al. |
Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A. |
2003 |
J. Med. Chem. |
pmid:14584932
|
Pace BS et al. |
p38 MAP kinase activation mediates gamma-globin gene induction in erythroid progenitors. |
2003 |
Exp. Hematol. |
pmid:14585374
|
Shteper PJ et al. |
Role of promoter methylation in regulation of the mammalian heparanase gene. |
2003 |
Oncogene |
pmid:14586400
|
Hirose T et al. |
p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. |
2003 |
Oncogene |
pmid:14586402
|
Vasudevan A et al. |
Heterocyclic ketones as inhibitors of histone deacetylase. |
2003 |
Bioorg. Med. Chem. Lett. |
pmid:14592473
|
Chung YL et al. |
A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. |
2003 |
Mol. Ther. |
pmid:14599803
|
Liu A et al. |
Oligodendrocyte process outgrowth in vitro is modulated by epigenetic regulation of cytoskeletal severing proteins. |
2003 |
Glia |
pmid:14603467
|
Moreira JM et al. |
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. |
2003 |
BMC Cancer |
pmid:14606959
|
Kim MS et al. |
Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. |
2003 |
Cancer Res. |
pmid:14612526
|
Miller TA et al. |
Histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:14613312
|
Hitomi T et al. |
p15(INK4b) in HDAC inhibitor-induced growth arrest. |
2003 |
FEBS Lett. |
pmid:14623092
|
Hejnar J et al. |
Demethylation of host-cell DNA at the site of avian retrovirus integration. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:14623319
|
Kramps C et al. |
E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas. |
2004 |
J. Biol. Chem. |
pmid:14645238
|
Wong JE et al. |
Therapeutic strategies in gastric cancer. |
2003 |
J. Clin. Oncol. |
pmid:14645406
|
Suzuki M et al. |
Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. |
2003 |
Oncogene |
pmid:14647463
|
Kim HS et al. |
Regulation of the tyrosine hydroxylase gene promoter by histone deacetylase inhibitors. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:14651963
|
Coombes MM et al. |
Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. |
2003 |
Oncogene |
pmid:14654786
|
Thelen P et al. |
Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells. |
2004 |
Int. J. Oncol. |
pmid:14654937
|
Shim JS et al. |
Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. |
2004 |
Oncogene |
pmid:14661058
|
Kim DK et al. |
Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:14667227
|
Brush MH et al. |
Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. |
2004 |
J. Biol. Chem. |
pmid:14670976
|
Jang ER et al. |
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen. |
2004 |
Oncogene |
pmid:14676837
|
Vaisburg A et al. |
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitors. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:14684344
|
Nambu Y et al. |
Transcription-coupled events associating with immunoglobulin switch region chromatin. |
2003 |
Science |
pmid:14684824
|
Obata T et al. |
Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. |
2003 |
Clin. Cancer Res. |
pmid:14695142
|
Terui T et al. |
Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. |
2003 |
Cancer Res. |
pmid:14695212
|
Leu TH et al. |
Participation of p97Eps8 in Src-mediated transformation. |
2004 |
J. Biol. Chem. |
pmid:14699156
|
Haggarty SJ et al. |
Small molecule modulation of the human chromatid decatenation checkpoint. |
2003 |
Chem. Biol. |
pmid:14700634
|
Pagans S et al. |
Repression by TTK69 of GAGA-mediated activation occurs in the absence of TTK69 binding to DNA and solely requires the contribution of the POZ/BTB domain of TTK69. |
2004 |
J. Biol. Chem. |
pmid:14701830
|
Yan C et al. |
A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression. |
2004 |
FASEB J. |
pmid:14715692
|
Sugimoto S et al. |
Expression and regulation of tumor suppressor gene maspin in human bladder cancer. |
2004 |
Cancer Lett. |
pmid:14732229
|
Christian M et al. |
Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. |
2004 |
J. Biol. Chem. |
pmid:14736873
|
Nishikawa J et al. |
Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line. |
2004 |
Virus Genes |
pmid:14739656
|
Wang DF et al. |
QSAR studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:14741273
|
Parekh-Olmedo H et al. |
The effect of hydroxyurea and trichostatin a on targeted nucleotide exchange in yeast and Mammalian cells. |
2003 |
Ann. N. Y. Acad. Sci. |
pmid:14751821
|
Lee JH et al. |
Histone deacetylase activity is required for embryonic stem cell differentiation. |
2004 |
Genesis |
pmid:14755802
|
Lemonde S et al. |
Cell type-dependent recruitment of trichostatin A-sensitive repression of the human 5-HT1A receptor gene. |
2004 |
J. Neurochem. |
pmid:14756806
|
Hattori N et al. |
Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. |
2004 |
J. Biol. Chem. |
pmid:14761969
|
Um SJ et al. |
In vitro antitumor potential of 4-BPRE, a butyryl aminophenyl ester of retinoic acid: role of the butyryl group. |
2004 |
Oncol. Rep. |
pmid:14767528
|
GarcÃa I et al. |
Chromatin rearrangements in the prnD-prnB bidirectional promoter: dependence on transcription factors. |
2004 |
Eukaryotic Cell |
pmid:14871945
|
Takai N et al. |
Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. |
2004 |
Clin. Cancer Res. |
pmid:14871994
|
Reifenberger J et al. |
Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. |
2004 |
Int. J. Cancer |
pmid:14961576
|
Mai A et al. |
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity. |
2004 |
J. Med. Chem. |
pmid:14971890
|
Milhem M et al. |
Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A. |
2004 |
Blood |
pmid:14976039
|
Agostinho M et al. |
Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis. |
2004 |
Mol. Biol. Cell |
pmid:14978217
|
Sakata R et al. |
Trichostatin A activates the osteopontin gene promoter through AP1 site. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:14985105
|
Lu XC et al. |
[Effect of inhibitors for demethylation and histone deacetylase on proliferation of cell line K562 and expression of tumor related genes]. |
2004 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:14989767
|
Nojima H et al. |
Increase in DNA methylation downregulates conceptus interferon-tau gene expression. |
2004 |
Mol. Reprod. Dev. |
pmid:14991730
|
Chua YL et al. |
Microarray analysis of chromatin-immunoprecipitated DNA identifies specific regions of tobacco genes associated with acetylated histones. |
2004 |
Plant J. |
pmid:14996214
|
Khan AN et al. |
An epigenetically altered tumor cell vaccine. |
2004 |
Cancer Immunol. Immunother. |
pmid:14997346
|
Ragno R et al. |
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies. |
2004 |
J. Med. Chem. |
pmid:14998325
|
Hwang CK et al. |
Transcriptional regulation of mouse mu opioid receptor gene by PU.1. |
2004 |
J. Biol. Chem. |
pmid:14998994
|
Astrand C et al. |
Trichostatin A reduces hormone-induced transcription of the MMTV promoter and has pleiotropic effects on its chromatin structure. |
2004 |
Eur. J. Biochem. |
pmid:15009194
|
Gray SG et al. |
Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines. |
2004 |
Int. J. Oncol. |
pmid:15010814
|
Huang H et al. |
Expression of P53, P21 in human lung adenocarcinoma A549 cell strains under hypoxia conditions and the effect of TSA on their expression. |
2003 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:15015635
|
Aapola U et al. |
Epigenetic modifications affect Dnmt3L expression. |
2004 |
Biochem. J. |
pmid:15015937
|
Knobbe CB et al. |
Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas. |
2004 |
J. Natl. Cancer Inst. |
pmid:15026474
|
Chung YL et al. |
Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. |
2004 |
Mol. Cancer Ther. |
pmid:15026552
|
Burton GR et al. |
Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis. |
2004 |
Gene |
pmid:15033539
|
David GL et al. |
MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine. |
2004 |
Cancer Biol. Ther. |
pmid:15034303
|
Liu X et al. |
Nuclear factor Y regulation and promoter transactivation of human ribonucleotide reductase subunit M2 gene in a Gemcitabine resistant KB clone. |
2004 |
Biochem. Pharmacol. |
pmid:15041467
|
Steiner E et al. |
SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15047174
|
Kypreou KP et al. |
Age-dependent response of lymphocytes in the induction of the linker histone variant, H1 degrees and histone H4 acetylation after treatment with the histone deacetylase inhibitor, trichostatin A. |
2004 |
Exp. Gerontol. |
pmid:15050280
|
Chen YX et al. |
[Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines]. |
2004 |
Zhonghua Yi Xue Za Zhi |
pmid:15059516
|
Hildmann C et al. |
A new amidohydrolase from Bordetella or Alcaligenes strain FB188 with similarities to histone deacetylases. |
2004 |
J. Bacteriol. |
pmid:15060035
|
Vorontsova M et al. |
Effect of 5-azacytidine and trichostatin A on somatic centromere association in wheat. |
2004 |
Genome |
pmid:15060593
|
Tong X et al. |
Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15063780
|
Ganslmayer M et al. |
A quadruple therapy synergistically blocks proliferation and promotes apoptosis of hepatoma cells. |
2004 |
Oncol. Rep. |
pmid:15069530
|
Margueron R et al. |
Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens. |
2004 |
J. Mol. Endocrinol. |
pmid:15072561
|
Romanski A et al. |
Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia. |
2004 |
Haematologica |
pmid:15075075
|
Ahmed S et al. |
A novel protein with similarities to Rb binding protein 2 compensates for loss of Chk1 function and affects histone modification in fission yeast. |
2004 |
Mol. Cell. Biol. |
pmid:15082762
|
Amor DJ et al. |
Human centromere repositioning "in progress". |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15084747
|
Milutinovic S et al. |
DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. |
2004 |
J. Biol. Chem. |
pmid:15087453
|
Chang HC et al. |
Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. |
2004 |
Cell. Signal. |
pmid:15093608
|
Munro J et al. |
Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. |
2004 |
Exp. Cell Res. |
pmid:15093749
|
Tani M et al. |
Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells. |
2004 |
Genes Chromosomes Cancer |
pmid:15101048
|
Jansen MS et al. |
Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15103026
|
Lasa A et al. |
MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias. |
2004 |
Leukemia |
pmid:15103390
|
Yokota T et al. |
Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. |
2004 |
Oncogene |
pmid:15107822
|
McGarry LC et al. |
Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. |
2004 |
Oncogene |
pmid:15107823
|
Nishino N et al. |
Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15109626
|
Marson CM et al. |
Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E,4E)-5-arylpenta-2,4-dienoic acid hydroxyamides. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15109636
|
Arapshian A et al. |
Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer. |
2004 |
Mol. Cancer |
pmid:15113415
|
Mizukami T et al. |
Effects of trichostatin a, a histone deacetylase inhibitor, on mouse gonadal development in vitro. |
2004 |
J. Reprod. Dev. |
pmid:15118250
|
Klampfer L et al. |
Requirement of histone deacetylase activity for signaling by STAT1. |
2004 |
J. Biol. Chem. |
pmid:15123634
|
Fu M et al. |
The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. |
2004 |
J. Biol. Chem. |
pmid:15123687
|
Phan D et al. |
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. |
2004 |
Cancer Res. |
pmid:15126343
|
Iezzi S et al. |
Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. |
2004 |
Dev. Cell |
pmid:15130492
|
Bort R et al. |
Role of hepatocyte nuclear factor 3 gamma in the expression of human CYP2C genes. |
2004 |
Arch. Biochem. Biophys. |
pmid:15130783
|
Ishii S et al. |
Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone. |
2004 |
Mol. Endocrinol. |
pmid:15131262
|
Winn RA and Heasley LE |
Gamma-catenin expression is reduced or absent in a subset of human non-small cell lung cancers, and its re-expression inhibits cell growth. |
2004 |
Chest |
pmid:15136458
|
Jin YH et al. |
Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. |
2004 |
J. Biol. Chem. |
pmid:15138260
|